本文へ
MMadical AI Use
例示病院

A navigator list for people overdue for cancer screening

この言語の本文は未訳のため、英語で表示しています。

例示シナリオです。計画用の合成であり、特定の査読試験の報告ではありません。

This is an illustrative composite, not a trial report. A registry ranks patients who are overdue for a fit test, mammogram, or other screening the health system already recommends. Navigators call down the list. Before anyone trusts the rank order, the team checks whether the score under-calls a language group, a neighborhood, or a payer. No detection-rate improvement is claimed. A biased rank can widen a gap the program meant to close.

臨床の場

A health-system population health team with navigators, working from an existing screening registry rather than from a new disease label.

ツールとベンダー

  • Population health registry
  • Outreach workqueue

出典

Illustrative composite, Madical AI Use · 2026年3月18日 · 年 2026

索引への追加 2026年3月18日

出典を開く

タグ

  • 集団
  • 公平
  • 検診

教育と市場把握のための条目。医療助言でも推奨でもありません。

関連シナリオ

この領域のすべて

公衆衛生と集団

公的プログラム

A wastewater trend brief for the public health desk

The U.S. CDC National Wastewater Surveillance System publishes pathogen trends from sewage, which health departments read next to emergency and lab data. Some jurisdictions add a statistical nowcast on top of that feed. This card is about the desk workflow, not a claim that a named model forecasts incidence with a stated error. Wastewater is a population signal. It does not diagnose a person.

CDC NWSS · Local epidemiology desk

ニュース · 2024事例を読む

画像と放射線

規制

Autonomous diabetic retinopathy screening in primary care

IDx-DR, now marketed as LumineticsCore by Digital Diagnostics, was authorized to screen adults with diabetes for more-than-mild diabetic retinopathy without an eye specialist reading the photo first. A primary care team captures images on a specified retinal camera and the software returns a refer-or-rescreen result. It is not a complete eye examination. Pregnancy and several existing retinal conditions sit outside the labeled use.

LumineticsCore (IDx-DR) · Digital Diagnostics · Topcon NW400

ニュース · 2018事例を読む

画像と放射線

論文

AI-supported reading in the MASAI mammography trial

The MASAI trial in Sweden randomly assigned screening mammograms to AI-supported reading or standard double reading without AI. Transpara scored each exam and routed lower scores to a single reader and the highest score to double reading, with detection marks available on higher-risk exams. This card quotes the prespecified interim safety analysis, not a claim that every screening program should switch.

Transpara 1.7.0 · ScreenPoint Medical

論文 · 2023事例を読む
スポンサー

このインデックスの臨床読者に届ける。

スポンサー枠を見る